

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.11153711 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.94166024 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.94166024 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.69027005 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.45720089 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.01607660 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.97730706 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.53832239 |
| 9 | negative T cell selection (GO:0043383) | 4.53483819 |
| 10 | negative thymic T cell selection (GO:0045060) | 4.45808788 |
| 11 | leukocyte aggregation (GO:0070486) | 4.41577410 |
| 12 | ribosomal small subunit assembly (GO:0000028) | 4.37627872 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.36414493 |
| 14 | mast cell activation (GO:0045576) | 4.33589295 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.25556228 |
| 16 | regulation of B cell differentiation (GO:0045577) | 4.11224542 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08671191 |
| 18 | negative regulation of cell killing (GO:0031342) | 4.08671191 |
| 19 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.98471777 |
| 20 | interferon-gamma production (GO:0032609) | 3.97494327 |
| 21 | T cell migration (GO:0072678) | 3.95293642 |
| 22 | positive thymic T cell selection (GO:0045059) | 3.94704401 |
| 23 | response to interleukin-15 (GO:0070672) | 3.90121059 |
| 24 | B cell receptor signaling pathway (GO:0050853) | 3.84978447 |
| 25 | negative regulation of phagocytosis (GO:0050765) | 3.80275405 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 3.76844157 |
| 27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.69250184 |
| 28 | activated T cell proliferation (GO:0050798) | 3.69231499 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 3.63294717 |
| 30 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.62840714 |
| 31 | defense response to protozoan (GO:0042832) | 3.55766983 |
| 32 | positive T cell selection (GO:0043368) | 3.52768878 |
| 33 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.52023361 |
| 34 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.49434411 |
| 35 | response to protozoan (GO:0001562) | 3.44483560 |
| 36 | mast cell degranulation (GO:0043303) | 3.42628479 |
| 37 | mast cell activation involved in immune response (GO:0002279) | 3.42628479 |
| 38 | thymic T cell selection (GO:0045061) | 3.42383541 |
| 39 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.42148509 |
| 40 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.40824748 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.40474654 |
| 42 | cellular response to interferon-beta (GO:0035458) | 3.39969148 |
| 43 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.39694501 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 3.35679342 |
| 45 | T cell selection (GO:0045058) | 3.35594318 |
| 46 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.35585885 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.34987345 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 3.33168681 |
| 49 | cytidine deamination (GO:0009972) | 3.32908932 |
| 50 | cytidine metabolic process (GO:0046087) | 3.32908932 |
| 51 | cytidine catabolic process (GO:0006216) | 3.32908932 |
| 52 | DNA deamination (GO:0045006) | 3.30930975 |
| 53 | T cell homeostasis (GO:0043029) | 3.29038868 |
| 54 | regulation of tolerance induction (GO:0002643) | 3.27745776 |
| 55 | cellular response to zinc ion (GO:0071294) | 3.27516045 |
| 56 | positive regulation of lamellipodium assembly (GO:0010592) | 3.24110997 |
| 57 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.21656043 |
| 58 | T cell receptor signaling pathway (GO:0050852) | 3.18834304 |
| 59 | sequestering of actin monomers (GO:0042989) | 3.18284960 |
| 60 | response to interferon-beta (GO:0035456) | 3.17206486 |
| 61 | cellular extravasation (GO:0045123) | 3.16992656 |
| 62 | regulation of regulatory T cell differentiation (GO:0045589) | 3.11651560 |
| 63 | response to type I interferon (GO:0034340) | 3.09412695 |
| 64 | type I interferon signaling pathway (GO:0060337) | 3.08811684 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.08811684 |
| 66 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.08354053 |
| 67 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.06767903 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 3.05231820 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04611477 |
| 70 | positive regulation of defense response to virus by host (GO:0002230) | 3.04008852 |
| 71 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.03399878 |
| 72 | neutrophil activation (GO:0042119) | 3.02271109 |
| 73 | hepatocyte apoptotic process (GO:0097284) | 2.99912402 |
| 74 | positive regulation of isotype switching (GO:0045830) | 2.98543951 |
| 75 | positive regulation of granulocyte differentiation (GO:0030854) | 2.98462408 |
| 76 | negative regulation of B cell proliferation (GO:0030889) | 2.98033998 |
| 77 | mature B cell differentiation (GO:0002335) | 2.95965658 |
| 78 | megakaryocyte development (GO:0035855) | 2.95295970 |
| 79 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.95104618 |
| 80 | actin nucleation (GO:0045010) | 2.94388838 |
| 81 | definitive hemopoiesis (GO:0060216) | 2.94276433 |
| 82 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.93714597 |
| 83 | neutrophil activation involved in immune response (GO:0002283) | 2.91567412 |
| 84 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.91499259 |
| 85 | T cell costimulation (GO:0031295) | 2.91169200 |
| 86 | lymphocyte homeostasis (GO:0002260) | 2.91071894 |
| 87 | lymphocyte costimulation (GO:0031294) | 2.90157283 |
| 88 | regulation of granulocyte differentiation (GO:0030852) | 2.89867668 |
| 89 | Peyers patch development (GO:0048541) | 2.89644026 |
| 90 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.89644026 |
| 91 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89064633 |
| 92 | respiratory burst (GO:0045730) | 2.88765574 |
| 93 | positive regulation of mast cell activation (GO:0033005) | 2.88253448 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 2.86970849 |
| 95 | positive regulation of tolerance induction (GO:0002645) | 2.84551347 |
| 96 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.84414965 |
| 97 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.84414965 |
| 98 | negative regulation of adaptive immune response (GO:0002820) | 2.84260988 |
| 99 | regulation of response to interferon-gamma (GO:0060330) | 2.83733156 |
| 100 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.83072344 |
| 101 | regulation of mast cell activation (GO:0033003) | 2.83005780 |
| 102 | B cell mediated immunity (GO:0019724) | 2.82365703 |
| 103 | microglial cell activation (GO:0001774) | 2.79392883 |
| 104 | tolerance induction (GO:0002507) | 2.79353175 |
| 105 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.77929505 |
| 106 | positive regulation of interleukin-2 production (GO:0032743) | 2.77002650 |
| 107 | leukocyte cell-cell adhesion (GO:0007159) | 2.76800477 |
| 108 | positive regulation of DNA recombination (GO:0045911) | 2.76217722 |
| 109 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76091298 |
| 110 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.76091298 |
| 111 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76091298 |
| 112 | modulation by symbiont of host immune response (GO:0052553) | 2.76091298 |
| 113 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76091298 |
| 114 | modulation by symbiont of host defense response (GO:0052031) | 2.76091298 |
| 115 | T cell proliferation (GO:0042098) | 2.74986710 |
| 116 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.74631012 |
| 117 | regulation of alpha-beta T cell activation (GO:0046634) | 2.74297065 |
| 118 | regulation of cell killing (GO:0031341) | 2.74003626 |
| 119 | NIK/NF-kappaB signaling (GO:0038061) | 2.73986673 |
| 120 | mature B cell differentiation involved in immune response (GO:0002313) | 2.73906782 |
| 121 | alpha-beta T cell differentiation (GO:0046632) | 2.73184062 |
| 122 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.72568672 |
| 123 | regulation of T cell mediated immunity (GO:0002709) | 2.72499558 |
| 124 | leukocyte degranulation (GO:0043299) | 2.68335835 |
| 125 | leukocyte homeostasis (GO:0001776) | 2.68005974 |
| 126 | regulation of B cell mediated immunity (GO:0002712) | 2.66382616 |
| 127 | positive regulation of lamellipodium organization (GO:1902745) | 2.66311777 |
| 128 | regulation of isotype switching (GO:0045191) | 2.65517525 |
| 129 | angiogenesis involved in wound healing (GO:0060055) | 2.63051384 |
| 130 | myeloid cell activation involved in immune response (GO:0002275) | 2.62515166 |
| 131 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.61912128 |
| 132 | positive regulation of macrophage differentiation (GO:0045651) | 2.61735903 |
| 133 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.60352607 |
| 134 | viral transcription (GO:0019083) | 2.60080577 |
| 135 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.58729612 |
| 136 | positive regulation of B cell mediated immunity (GO:0002714) | 2.58729612 |
| 137 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.57559845 |
| 138 | regulation of necroptotic process (GO:0060544) | 2.57544827 |
| 139 | positive regulation of B cell activation (GO:0050871) | 2.56883914 |
| 140 | neutrophil mediated immunity (GO:0002446) | 2.56475717 |
| 141 | necroptotic process (GO:0070266) | 2.54752303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.54750239 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.66497712 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.47744424 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.01175641 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.01032326 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.61339217 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.31371059 |
| 8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.22313101 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.03216771 |
| 10 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.97891441 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.80577575 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.74711688 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72618038 |
| 14 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.66484777 |
| 15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62264694 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62081108 |
| 17 | * MYB_26560356_Chip-Seq_TH2_Human | 2.48952846 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48476277 |
| 19 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48344999 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.45924476 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.45790535 |
| 22 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44204175 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.40797605 |
| 24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37488115 |
| 25 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30316410 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23046949 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.21834989 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18918395 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.15784376 |
| 30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12536759 |
| 31 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.09407054 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.06408288 |
| 33 | * MAF_26560356_Chip-Seq_TH1_Human | 2.06081132 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.04621447 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98961720 |
| 36 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92426581 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91389162 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89554828 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.88353276 |
| 40 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87916031 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87263586 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.85779369 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.85209862 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80419148 |
| 45 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.79981670 |
| 46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.78576444 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77404144 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71730199 |
| 49 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.70423192 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67725231 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.67111830 |
| 52 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62042056 |
| 53 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61055230 |
| 54 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56970019 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56639378 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.56118958 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56117726 |
| 58 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.52780259 |
| 59 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52468621 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51005176 |
| 61 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50786978 |
| 62 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.48645891 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48215007 |
| 64 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47601236 |
| 65 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.46759547 |
| 66 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46295415 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45761564 |
| 68 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44233105 |
| 69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.35496730 |
| 70 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.34450338 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33386703 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.32794354 |
| 73 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32674121 |
| 74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30477966 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30428102 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29986211 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27821372 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21865024 |
| 79 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21276146 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.18741310 |
| 81 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.17811238 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16316100 |
| 83 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14854452 |
| 84 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.13599637 |
| 85 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12405902 |
| 86 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.11591464 |
| 87 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10688142 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08977907 |
| 89 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08739012 |
| 90 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08418224 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07866504 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07718047 |
| 93 | * GATA3_26560356_Chip-Seq_TH1_Human | 1.05828263 |
| 94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04612076 |
| 95 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.04566418 |
| 96 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04330242 |
| 97 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.03454780 |
| 98 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.03266209 |
| 99 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.02703138 |
| 100 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02397637 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02383532 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01959463 |
| 103 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01290258 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00851632 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00673742 |
| 106 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99933385 |
| 107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99871660 |
| 108 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98453789 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97944132 |
| 110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96236914 |
| 111 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96165733 |
| 112 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94371984 |
| 113 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.94133671 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93871343 |
| 115 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93241080 |
| 116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92951322 |
| 117 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92550985 |
| 118 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92502226 |
| 119 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90620717 |
| 120 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90443582 |
| 121 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90261285 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89710596 |
| 123 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.89306192 |
| 124 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.88341734 |
| 125 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88027680 |
| 126 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.87963799 |
| 127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87658620 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86496151 |
| 129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85662950 |
| 130 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85370298 |
| 131 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.84919003 |
| 132 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83985256 |
| 133 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83832694 |
| 134 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83713614 |
| 135 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83535098 |
| 136 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.82544918 |
| 137 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81980272 |
| 138 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81206098 |
| 139 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79717861 |
| 140 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.79535307 |
| 141 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.79370207 |
| 142 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.78251294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.64528396 |
| 2 | MP0005671_abnormal_response_to | 3.83129225 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.62316556 |
| 4 | MP0000685_abnormal_immune_system | 3.56211284 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.48007435 |
| 6 | MP0009785_altered_susceptibility_to | 3.21090199 |
| 7 | MP0001800_abnormal_humoral_immune | 3.09919282 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.89825283 |
| 9 | MP0002420_abnormal_adaptive_immunity | 2.80846365 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.77764478 |
| 11 | MP0001790_abnormal_immune_system | 2.77616163 |
| 12 | MP0005387_immune_system_phenotype | 2.77616163 |
| 13 | MP0001819_abnormal_immune_cell | 2.77192148 |
| 14 | MP0005025_abnormal_response_to | 2.75715013 |
| 15 | MP0002723_abnormal_immune_serum | 2.74247886 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.73775651 |
| 17 | MP0003436_decreased_susceptibility_to | 2.72400448 |
| 18 | MP0002398_abnormal_bone_marrow | 2.68834315 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.58453843 |
| 20 | MP0002419_abnormal_innate_immunity | 2.53589944 |
| 21 | MP0000716_abnormal_immune_system | 2.37509387 |
| 22 | MP0003724_increased_susceptibility_to | 2.23982992 |
| 23 | MP0000689_abnormal_spleen_morphology | 2.23888779 |
| 24 | MP0002006_tumorigenesis | 2.21953296 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.19637776 |
| 26 | MP0002722_abnormal_immune_system | 2.12614392 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.11247438 |
| 28 | MP0001853_heart_inflammation | 2.10115781 |
| 29 | MP0002405_respiratory_system_inflammati | 2.08948185 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 2.07747692 |
| 31 | MP0002429_abnormal_blood_cell | 2.01256760 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.97113076 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.96512045 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.90620480 |
| 35 | MP0001873_stomach_inflammation | 1.82223190 |
| 36 | MP0003866_abnormal_defecation | 1.80273590 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.76243104 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.76243104 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.69361143 |
| 40 | MP0003303_peritoneal_inflammation | 1.68980914 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.67947225 |
| 42 | MP0006082_CNS_inflammation | 1.67562549 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.64489647 |
| 44 | MP0010094_abnormal_chromosome_stability | 1.56209762 |
| 45 | MP0000490_abnormal_crypts_of | 1.46725761 |
| 46 | MP0004947_skin_inflammation | 1.46397438 |
| 47 | MP0008057_abnormal_DNA_replication | 1.44077822 |
| 48 | MP0000858_altered_metastatic_potential | 1.36467934 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.35098460 |
| 50 | MP0008469_abnormal_protein_level | 1.34459766 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.33271592 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.30141353 |
| 53 | MP0003693_abnormal_embryo_hatching | 1.21273977 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.20416417 |
| 55 | MP0002933_joint_inflammation | 1.19234942 |
| 56 | MP0003077_abnormal_cell_cycle | 1.18140351 |
| 57 | MP0002095_abnormal_skin_pigmentation | 1.17986054 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.16006765 |
| 59 | MP0008007_abnormal_cellular_replicative | 1.11741776 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.09554440 |
| 61 | MP0008058_abnormal_DNA_repair | 1.08959315 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.06228958 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.04251840 |
| 64 | MP0009278_abnormal_bone_marrow | 1.00666826 |
| 65 | MP0003787_abnormal_imprinting | 0.98255689 |
| 66 | MP0005310_abnormal_salivary_gland | 0.98040038 |
| 67 | MP0003172_abnormal_lysosome_physiology | 0.97876947 |
| 68 | MP0003045_fibrosis | 0.97304134 |
| 69 | MP0003111_abnormal_nucleus_morphology | 0.96847838 |
| 70 | MP0002009_preneoplasia | 0.96846419 |
| 71 | MP0003448_altered_tumor_morphology | 0.95697512 |
| 72 | MP0000343_altered_response_to | 0.95198259 |
| 73 | MP0000569_abnormal_digit_pigmentation | 0.92807724 |
| 74 | MP0009764_decreased_sensitivity_to | 0.91041256 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 0.89467691 |
| 76 | MP0004381_abnormal_hair_follicle | 0.88199359 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.87691932 |
| 78 | MP0006054_spinal_hemorrhage | 0.87240308 |
| 79 | MP0004510_myositis | 0.85111808 |
| 80 | MP0002132_abnormal_respiratory_system | 0.84907807 |
| 81 | MP0009763_increased_sensitivity_to | 0.79383188 |
| 82 | MP0001851_eye_inflammation | 0.78740118 |
| 83 | MP0008872_abnormal_physiological_respon | 0.78640766 |
| 84 | MP0003195_calcinosis | 0.77698185 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 0.75646298 |
| 86 | MP0003252_abnormal_bile_duct | 0.74565541 |
| 87 | MP0002163_abnormal_gland_morphology | 0.74560651 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.72653601 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.72482553 |
| 90 | MP0003646_muscle_fatigue | 0.71954431 |
| 91 | MP0001501_abnormal_sleep_pattern | 0.71615165 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.69685428 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.69523799 |
| 94 | MP0004883_abnormal_blood_vessel | 0.69426078 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.68575935 |
| 96 | MP0010307_abnormal_tumor_latency | 0.68196340 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.66673410 |
| 98 | MP0000313_abnormal_cell_death | 0.65353020 |
| 99 | MP0005645_abnormal_hypothalamus_physiol | 0.65334384 |
| 100 | MP0001919_abnormal_reproductive_system | 0.65320191 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.65237969 |
| 102 | MP0003075_altered_response_to | 0.62878567 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.62502530 |
| 104 | MP0004130_abnormal_muscle_cell | 0.62202996 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.61872561 |
| 106 | MP0008873_increased_physiological_sensi | 0.60534420 |
| 107 | MP0010352_gastrointestinal_tract_polyps | 0.60121370 |
| 108 | MP0004484_altered_response_of | 0.59491423 |
| 109 | MP0001663_abnormal_digestive_system | 0.59380926 |
| 110 | MP0005166_decreased_susceptibility_to | 0.58837729 |
| 111 | MP0004147_increased_porphyrin_level | 0.56409398 |
| 112 | MP0003828_pulmonary_edema | 0.55575884 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.55365668 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.54171471 |
| 115 | MP0008877_abnormal_DNA_methylation | 0.53221245 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.51839819 |
| 117 | MP0000249_abnormal_blood_vessel | 0.50995752 |
| 118 | MP0005409_darkened_coat_color | 0.50034906 |
| 119 | MP0000371_diluted_coat_color | 0.45949376 |
| 120 | MP0000477_abnormal_intestine_morphology | 0.45445695 |
| 121 | MP0008874_decreased_physiological_sensi | 0.45203322 |
| 122 | MP0000604_amyloidosis | 0.44491678 |
| 123 | MP0003786_premature_aging | 0.43449212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.68637042 |
| 2 | IgM deficiency (HP:0002850) | 4.96018962 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.79024614 |
| 4 | Myositis (HP:0100614) | 4.43142033 |
| 5 | Chronic otitis media (HP:0000389) | 4.35924341 |
| 6 | Thrombocytosis (HP:0001894) | 4.29883534 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.20276871 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.19224866 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.11444148 |
| 10 | Recurrent viral infections (HP:0004429) | 4.09268167 |
| 11 | Stomatitis (HP:0010280) | 4.07646292 |
| 12 | T lymphocytopenia (HP:0005403) | 4.02337129 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.02061555 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.95840497 |
| 15 | IgG deficiency (HP:0004315) | 3.87825857 |
| 16 | Abnormality of T cells (HP:0002843) | 3.87603936 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.83442981 |
| 18 | Meningitis (HP:0001287) | 3.66219162 |
| 19 | Abnormality of B cell number (HP:0010975) | 3.62491699 |
| 20 | B lymphocytopenia (HP:0010976) | 3.62491699 |
| 21 | Abnormality of T cell physiology (HP:0011840) | 3.55310416 |
| 22 | Agammaglobulinemia (HP:0004432) | 3.53937376 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.48638049 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.48638049 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46584822 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.43608539 |
| 27 | Thyroiditis (HP:0100646) | 3.31835179 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.30873938 |
| 29 | Recurrent skin infections (HP:0001581) | 3.29994055 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19253530 |
| 31 | Obstructive lung disease (HP:0006536) | 3.19253530 |
| 32 | Combined immunodeficiency (HP:0005387) | 3.16162109 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 3.12383339 |
| 34 | Optic neuritis (HP:0100653) | 3.12383339 |
| 35 | Petechiae (HP:0000967) | 3.10981302 |
| 36 | Abnormality of the prostate (HP:0008775) | 3.02626954 |
| 37 | Lymphopenia (HP:0001888) | 3.02009967 |
| 38 | Aplastic anemia (HP:0001915) | 3.01807836 |
| 39 | Abnormality of the fingertips (HP:0001211) | 3.01332301 |
| 40 | Vasculitis (HP:0002633) | 3.00983377 |
| 41 | Orchitis (HP:0100796) | 3.00368040 |
| 42 | Leukocytosis (HP:0001974) | 2.89721710 |
| 43 | Stomach cancer (HP:0012126) | 2.89004546 |
| 44 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.87855044 |
| 45 | Cellulitis (HP:0100658) | 2.87817782 |
| 46 | Eosinophilia (HP:0001880) | 2.86723459 |
| 47 | Abnormality of eosinophils (HP:0001879) | 2.86486291 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.85914456 |
| 49 | Lymphoma (HP:0002665) | 2.84277906 |
| 50 | Increased IgM level (HP:0003496) | 2.83836549 |
| 51 | Nasal polyposis (HP:0100582) | 2.82830754 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.80634240 |
| 53 | Encephalitis (HP:0002383) | 2.79023956 |
| 54 | Granulocytopenia (HP:0001913) | 2.73985380 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.72214465 |
| 56 | Hypoplasia of the thymus (HP:0000778) | 2.70252493 |
| 57 | Recurrent sinusitis (HP:0011108) | 2.69987135 |
| 58 | Hypergammaglobulinemia (HP:0010702) | 2.64961340 |
| 59 | IgA deficiency (HP:0002720) | 2.64230509 |
| 60 | Chronic diarrhea (HP:0002028) | 2.64051736 |
| 61 | Gangrene (HP:0100758) | 2.63487592 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.59888036 |
| 63 | Epistaxis (HP:0000421) | 2.56805250 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52461163 |
| 65 | Chest pain (HP:0100749) | 2.51680944 |
| 66 | Pulmonary embolism (HP:0002204) | 2.51346185 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.47798276 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.46640406 |
| 69 | Abnormality of the pleura (HP:0002103) | 2.45310532 |
| 70 | Abnormal number of erythroid precursors (HP:0012131) | 2.44621663 |
| 71 | Hypoproteinemia (HP:0003075) | 2.43282497 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.42893080 |
| 73 | Gastrointestinal stroma tumor (HP:0100723) | 2.42119640 |
| 74 | Abnormality of the nasal mucosa (HP:0000433) | 2.40767276 |
| 75 | Reticulocytopenia (HP:0001896) | 2.39913562 |
| 76 | Hemoptysis (HP:0002105) | 2.39857775 |
| 77 | Gingivitis (HP:0000230) | 2.39586967 |
| 78 | Pustule (HP:0200039) | 2.38159566 |
| 79 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.36569741 |
| 80 | Periodontitis (HP:0000704) | 2.35724308 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.32837692 |
| 82 | Anorexia (HP:0002039) | 2.32594815 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 2.31845568 |
| 84 | Bronchitis (HP:0012387) | 2.31672107 |
| 85 | Colitis (HP:0002583) | 2.30891651 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 2.28485472 |
| 87 | Joint swelling (HP:0001386) | 2.27504963 |
| 88 | Chronic sinusitis (HP:0011109) | 2.26278836 |
| 89 | Arterial thrombosis (HP:0004420) | 2.23553343 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21859085 |
| 91 | Prostate neoplasm (HP:0100787) | 2.21205702 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 2.19468350 |
| 93 | Recurrent pneumonia (HP:0006532) | 2.19063280 |
| 94 | Keratoconjunctivitis (HP:0001096) | 2.18373580 |
| 95 | Neutropenia (HP:0001875) | 2.18298454 |
| 96 | Increased IgE level (HP:0003212) | 2.18277087 |
| 97 | Amaurosis fugax (HP:0100576) | 2.16864309 |
| 98 | Alveolar cell carcinoma (HP:0006519) | 2.15037345 |
| 99 | Osteomyelitis (HP:0002754) | 2.14956267 |
| 100 | Gingival bleeding (HP:0000225) | 2.11745939 |
| 101 | Polyneuropathy (HP:0001271) | 2.10587079 |
| 102 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.09382701 |
| 103 | Poikiloderma (HP:0001029) | 2.08090350 |
| 104 | Sepsis (HP:0100806) | 2.07353788 |
| 105 | Urticaria (HP:0001025) | 2.06449611 |
| 106 | Keratitis (HP:0000491) | 2.05682966 |
| 107 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05587595 |
| 108 | Myelodysplasia (HP:0002863) | 2.05075461 |
| 109 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.03040153 |
| 110 | Congenital stationary night blindness (HP:0007642) | 2.02044300 |
| 111 | Vertigo (HP:0002321) | 1.99281615 |
| 112 | Skin rash (HP:0000988) | 1.97273831 |
| 113 | Abnormality of male internal genitalia (HP:0000022) | 1.96986239 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.96882382 |
| 115 | Abnormal platelet function (HP:0011869) | 1.96882382 |
| 116 | Papilloma (HP:0012740) | 1.96452495 |
| 117 | Verrucae (HP:0200043) | 1.96452495 |
| 118 | Hypochromic anemia (HP:0001931) | 1.95820087 |
| 119 | Pulmonary fibrosis (HP:0002206) | 1.95577580 |
| 120 | Glomerulopathy (HP:0100820) | 1.95171391 |
| 121 | Attenuation of retinal blood vessels (HP:0007843) | 1.94796029 |
| 122 | Acute hepatic failure (HP:0006554) | 1.94579367 |
| 123 | Thrombophlebitis (HP:0004418) | 1.90180470 |
| 124 | Increased cerebral lipofuscin (HP:0011813) | 1.85849653 |
| 125 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81061016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.89204327 |
| 2 | TXK | 4.30356340 |
| 3 | FRK | 3.17733683 |
| 4 | KIT | 2.94536189 |
| 5 | MAP3K12 | 2.80175958 |
| 6 | TEC | 2.68008108 |
| 7 | ZAP70 | 2.61808673 |
| 8 | IRAK4 | 2.46583498 |
| 9 | BTK | 2.41405989 |
| 10 | TYK2 | 2.27396021 |
| 11 | JAK3 | 2.26836236 |
| 12 | IKBKE | 2.19173574 |
| 13 | ITK | 2.08003590 |
| 14 | BLK | 2.07368740 |
| 15 | BMPR2 | 2.05339201 |
| 16 | SYK | 1.94298593 |
| 17 | PIK3CG | 1.93325462 |
| 18 | MAP3K14 | 1.91777848 |
| 19 | FLT3 | 1.80688921 |
| 20 | STK10 | 1.76100878 |
| 21 | GRK6 | 1.72703355 |
| 22 | CSF1R | 1.69645949 |
| 23 | TBK1 | 1.67214912 |
| 24 | TAOK3 | 1.67018526 |
| 25 | LCK | 1.62468301 |
| 26 | RIPK4 | 1.53920625 |
| 27 | ZAK | 1.43221182 |
| 28 | CLK1 | 1.41824543 |
| 29 | NUAK1 | 1.41112761 |
| 30 | JAK1 | 1.39329771 |
| 31 | MAP3K13 | 1.39006632 |
| 32 | TNK2 | 1.37692624 |
| 33 | IKBKB | 1.37063575 |
| 34 | MAP2K3 | 1.34536417 |
| 35 | NME2 | 1.30801911 |
| 36 | LYN | 1.29979327 |
| 37 | HCK | 1.29503829 |
| 38 | FES | 1.28992396 |
| 39 | PIM1 | 1.25924958 |
| 40 | VRK1 | 1.21361474 |
| 41 | MAP4K2 | 1.19035889 |
| 42 | MKNK1 | 1.17127258 |
| 43 | PIM2 | 1.12991453 |
| 44 | TESK2 | 1.11958596 |
| 45 | STK16 | 1.11331848 |
| 46 | EEF2K | 1.10276691 |
| 47 | IRAK3 | 1.07218601 |
| 48 | KDR | 1.05037200 |
| 49 | IRAK1 | 1.01573567 |
| 50 | BCKDK | 0.95592909 |
| 51 | NLK | 0.94670936 |
| 52 | CSK | 0.93545853 |
| 53 | MAPKAPK5 | 0.93229743 |
| 54 | FGFR4 | 0.91157119 |
| 55 | DAPK1 | 0.87609033 |
| 56 | GRK7 | 0.85164222 |
| 57 | LRRK2 | 0.84755995 |
| 58 | EIF2AK3 | 0.83738251 |
| 59 | CDC7 | 0.81579043 |
| 60 | MST4 | 0.81198724 |
| 61 | ACVR1B | 0.80586061 |
| 62 | FGFR3 | 0.77483024 |
| 63 | TGFBR2 | 0.73946014 |
| 64 | TGFBR1 | 0.72876408 |
| 65 | STK4 | 0.71593301 |
| 66 | WEE1 | 0.71401737 |
| 67 | ADRBK2 | 0.70795630 |
| 68 | CHUK | 0.70312251 |
| 69 | PRKCQ | 0.68449393 |
| 70 | MUSK | 0.67109043 |
| 71 | PINK1 | 0.66392797 |
| 72 | MAP2K2 | 0.65069702 |
| 73 | ATR | 0.64998331 |
| 74 | MATK | 0.63463079 |
| 75 | MAPK4 | 0.63339133 |
| 76 | TLK1 | 0.63027382 |
| 77 | GRK1 | 0.62725699 |
| 78 | OXSR1 | 0.62295806 |
| 79 | JAK2 | 0.62214491 |
| 80 | BMPR1B | 0.61254247 |
| 81 | EPHA3 | 0.61046055 |
| 82 | MYLK | 0.60233605 |
| 83 | PDK1 | 0.59653521 |
| 84 | CAMKK2 | 0.58238212 |
| 85 | CCNB1 | 0.57746019 |
| 86 | BUB1 | 0.57387674 |
| 87 | CDK8 | 0.57111616 |
| 88 | ERN1 | 0.56098750 |
| 89 | BRSK2 | 0.55489969 |
| 90 | CDK4 | 0.54638741 |
| 91 | TNIK | 0.53850533 |
| 92 | MAP3K10 | 0.53795849 |
| 93 | RPS6KA6 | 0.53286057 |
| 94 | CDK19 | 0.52367919 |
| 95 | SIK3 | 0.50862973 |
| 96 | SRPK1 | 0.50655937 |
| 97 | MARK3 | 0.49972755 |
| 98 | EIF2AK1 | 0.49325093 |
| 99 | RPS6KB2 | 0.48281176 |
| 100 | DAPK2 | 0.47867315 |
| 101 | TRPM7 | 0.47408044 |
| 102 | MAP3K11 | 0.47383595 |
| 103 | MAP3K6 | 0.46975177 |
| 104 | PTK2B | 0.46902839 |
| 105 | GRK5 | 0.46881061 |
| 106 | ADRBK1 | 0.46231499 |
| 107 | RPS6KA4 | 0.45886155 |
| 108 | IGF1R | 0.45167522 |
| 109 | MAPK13 | 0.44800137 |
| 110 | SIK2 | 0.43626730 |
| 111 | RPS6KA5 | 0.43515830 |
| 112 | ABL1 | 0.42527932 |
| 113 | MAP3K1 | 0.42217415 |
| 114 | FYN | 0.41678339 |
| 115 | CAMKK1 | 0.40906078 |
| 116 | MAP2K6 | 0.39556954 |
| 117 | HIPK2 | 0.39275330 |
| 118 | RPS6KC1 | 0.39268074 |
| 119 | RPS6KL1 | 0.39268074 |
| 120 | FGR | 0.39240209 |
| 121 | BRD4 | 0.37943289 |
| 122 | MAPK11 | 0.37348707 |
| 123 | NEK2 | 0.37244041 |
| 124 | PASK | 0.36606619 |
| 125 | PRKCD | 0.35656189 |
| 126 | PKN2 | 0.35619323 |
| 127 | CDK6 | 0.35431880 |
| 128 | MAPK7 | 0.35373830 |
| 129 | PRKCH | 0.33116449 |
| 130 | MAP3K5 | 0.32480195 |
| 131 | PIK3CA | 0.30456904 |
| 132 | STK11 | 0.30160990 |
| 133 | TRIM28 | 0.30113075 |
| 134 | SCYL2 | 0.28968804 |
| 135 | INSRR | 0.28310951 |
| 136 | EGFR | 0.27680624 |
| 137 | MAPK3 | 0.27005353 |
| 138 | EPHB1 | 0.23821792 |
| 139 | MAP3K3 | 0.23593149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.55324950 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.90346557 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66658084 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.42791327 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.35261991 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.33632081 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30456780 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.29325917 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.28162115 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.20000436 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18495634 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 2.17304211 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 2.16486019 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13610928 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12664659 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05643188 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 2.04928075 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.79000723 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.77847869 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76509578 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74280952 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71655818 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62474918 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.55504365 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53465143 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43963858 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42560505 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41621710 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.37520430 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35210029 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.34227035 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.30484659 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29331245 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26273314 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.25604456 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.24499668 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21400187 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.18913442 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.15516587 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12518658 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.10894479 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10476441 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10323469 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09645049 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.03980631 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02930491 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.02610417 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.02407989 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.01322750 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99903391 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98376833 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.97550395 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96708560 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92868608 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.91941309 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.90862161 |
| 57 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.90412076 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88964201 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.85865322 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.85216610 |
| 61 | Cell cycle_Homo sapiens_hsa04110 | 0.84241019 |
| 62 | Proteasome_Homo sapiens_hsa03050 | 0.81958876 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78432183 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77701681 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75324518 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74609443 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74360283 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74328634 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73130054 |
| 70 | RNA polymerase_Homo sapiens_hsa03020 | 0.71490439 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71031773 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68179828 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67113167 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.64784338 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64742559 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62613392 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62365896 |
| 78 | Protein export_Homo sapiens_hsa03060 | 0.61890743 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61084374 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60733496 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60537674 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60069607 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59547674 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58703518 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57137540 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57096489 |
| 87 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56604636 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54834183 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54721764 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54409262 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54151795 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52110915 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51682556 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51449374 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49424081 |
| 96 | RNA transport_Homo sapiens_hsa03013 | 0.49370981 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49353849 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47796122 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47056937 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44511635 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42867839 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42574078 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41705932 |
| 104 | Purine metabolism_Homo sapiens_hsa00230 | 0.40706685 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40496458 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39153657 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.38793910 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37489098 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36354728 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35086188 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34926849 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34551276 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34014421 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.31554616 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.31059083 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30837234 |
| 117 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.29509766 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.27721696 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27688840 |
| 120 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27686243 |
| 121 | Salivary secretion_Homo sapiens_hsa04970 | 0.20652287 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17609016 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17500335 |
| 124 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.16305717 |
| 125 | Morphine addiction_Homo sapiens_hsa05032 | 0.13723240 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | 0.13578051 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13284586 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.12460686 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11551217 |

